C-reactive protein and the risk of developing hypertension.
about
Vascular function, inflammation, and variations in cardiac autonomic responses to particulate matter among weldersRosuvastatin, inflammation, C-reactive protein, JUPITER, and primary prevention of cardiovascular disease--a perspectiveThe Link between Fetal Programming, Inflammation, Muscular Strength, and Blood PressureFcγ receptors and ligands and cardiovascular diseaseRelations of plasma high-sensitivity C-reactive protein to various cardiovascular risk factorsHypertension: endothelial dysfunction, the prothrombotic state and antithrombotic therapyDoes farming have an effect on health status? A comparison study in west GreeceElevated C-reactive protein in children from risky neighborhoods: evidence for a stress pathway linking neighborhoods and inflammation in childrenBlood and CSF biomarkers in brain subcortical ischemic vascular disease: Involved pathways and clinical applicabilityThe Malaria-High Blood Pressure Hypothesis.Role of the immune system in hypertension: modulation by dietary antioxidants.Association of exome sequences with plasma C-reactive protein levels in >9000 participants.Lone mothers are at higher risk for cardiovascular disease compared with partnered mothers. Data from the National Health and Nutrition Examination Survey III (NHANES III).Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRPEvaluation of plasma chemerin levels in patients with non-dipper blood pressure patternsTime-cumulated blood pressure exposure and incident impairment of glucose tolerance and diabetes mellitus.Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort studyRosuvastatin attenuates the elevation in blood pressure induced by overexpression of human C-reactive protein.The role of CRP and inflammation in the pathogenesis of age-related macular degeneration.The relationship between inflammation, obesity and risk for hypertension in the Multi-Ethnic Study of Atherosclerosis (MESA).Serum levels of the Th1 chemoattractant interferon-gamma-inducible protein (IP) 10 are elevated in patients with essential hypertension.Tumor Necrosis Factor-α Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis.Obesity and inflammation: the linking mechanism and the complicationsRisk of hypertension and reduced kidney function after acute gastroenteritis from bacteria-contaminated drinking waterIs there an association between periodontitis and hypertension?Novel risk factors in long-term hypertension incidence in type 1 diabetes mellitusRelations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflectionPersonality and inflammation: the protective effect of openness to experience.Roles of inflammation, oxidative stress, and vascular dysfunction in hypertension.Association between daily cigarette consumption and hypertension moderated by CYP2A6 genotypes in Chinese male current smokers.Carotid artery stiffness, high-density lipoprotein cholesterol and inflammation in men with pre-hypertension.Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial.Enhanced blood pressure variability in a high cardiovascular risk group of African Americans: FIT4Life Study.Interaction of inflammation, hyperuricemia, and the prevalence of hypertension among adults free of metabolic syndrome: NHANES 2009-2010.Downregulation of alpha7 nicotinic acetylcholine receptor in two-kidney one-clip hypertensive rats.Hyperhomocysteinemia, Insulin Resistance and High HS- CRP Levels in Prehypertension.Multimarker approach for the prediction of heart failure incidence in the communitySerum cystatin C and the incidence of hypertension in type 1 diabetes mellitus.High-normal blood pressure and long-term risk of type 2 diabetes: 35-year prospective population based cohort study of men.
P2860
Q23921422-33D1171B-1B97-46B3-8270-8D6A9CF21345Q24594814-F5A3A6FF-667B-49EE-9FEE-457DDFE91412Q26778523-37641993-715E-4131-9358-749054346FD3Q27021449-210C5D02-6CB2-434D-9785-53B90EEAB5C2Q28177167-218DDAF9-1FAB-4C29-969F-D01157D13CB5Q28210055-F0DAF38D-46B8-426D-9269-1613BC15BA72Q28385511-65637148-D8C2-4B1A-AC30-B59B203C3E35Q28389077-EACC20AE-63B2-4110-A07A-516BB77A7B6DQ28604099-0775495F-5D3E-4CCA-AE11-1E2E5AB8CE3EQ30251413-50009D47-1E97-44D2-8C8E-5A8ABE8FD157Q30424339-581DBF58-AD2E-42D5-AE22-1840EFD6A0B2Q30459027-9CE8D491-AC27-4147-BC76-DD39807C29F4Q31001982-B66286B8-8DE1-4BEA-B44A-63FD47984A9FQ33377856-2E85AA40-D880-4C06-BED1-3317BAFDF035Q33412124-7538599E-548F-4A92-A344-BAE546E194EFQ33568442-8FB802B4-3B56-499B-9006-DD0A60B527A1Q33629776-A6E5F986-1B85-4FB8-A705-706029E6F6AEQ33699467-35D4AC99-0DD6-4000-866B-290C7BCF64DCQ33702090-54CEA806-3C03-48AD-B4D6-FF348226AE89Q33773157-0BE14826-BA7C-4BE1-8AB3-183BCABA0D4BQ33790556-B4969B5A-550E-4C05-9742-6AC96730A98DQ33791834-727F0DBA-F90B-4A0C-AE3E-45AA0C2F9243Q33871929-D589542F-6237-4293-902E-800212A3A3A9Q33897331-D97A08AE-7B58-43C7-84CF-534A8D9FAE63Q33906207-5B91D59B-8ADC-4835-B636-83C2DC0A572CQ33912011-901A8B32-6904-464B-A8BA-8C1712DD4EEFQ33940455-C4221606-35D8-44B1-9F7B-FA8EBF4DAE27Q33944402-DA582516-401D-456E-8FC5-778952C030F9Q33966450-962CBFE1-B554-4558-B14D-462B9E93D2FDQ34013918-F6C8F4A8-F9B2-4B69-90DF-0E57D67FD0BAQ34028131-9F288A4E-1D4B-4FE2-B35B-2DDEC91EFDE8Q34038348-067FAB0E-98F9-42A2-B283-B65EA160687DQ34125876-1F631592-8350-49A6-8EE6-AB7299EC1767Q34156647-58DB7767-672C-421B-9A47-F186E90D451CQ34297252-2D4D0351-9D20-403F-A991-0FBF52F2002BQ34298068-E997E045-52FB-4A65-A5D2-B4B9619C8F5CQ34310559-6E7CCC78-7BBE-4C59-BCC6-9A21908CA0D4Q34357369-ED7ACBD6-EA7B-4233-8ED8-BCAE3032E783Q34414184-3F8D8740-0FDD-439D-88E5-EF82BE9D0AE4Q34445919-5B9005F9-BBE9-4084-9050-B8A2A9A0206C
P2860
C-reactive protein and the risk of developing hypertension.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
C-reactive protein and the risk of developing hypertension.
@en
type
label
C-reactive protein and the risk of developing hypertension.
@en
prefLabel
C-reactive protein and the risk of developing hypertension.
@en
P2093
P356
P1476
C-reactive protein and the risk of developing hypertension.
@en
P2093
Gavin J Blake
Howard D Sesso
J Michael Gaziano
Paul M Ridker
P304
P356
10.1001/JAMA.290.22.2945
P407
P577
2003-12-01T00:00:00Z